NCT05987644 - Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2027

Conditions

Lung CancerNSCLCBrain Metastases

Interventions

DRUG

Alectinib

600mg taken orally, twice daily for 25 Cycles Cycle = 4 weeks (28 days)

RADIATION

Stereotactic Radiosurgery

SRS dose varies by brain met size and location

Trial Locations (3)

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

RECRUITING

University of Colorado Cancer Center, Aurora

RECRUITING

Stanford University, Stanford